MedBen Rx
  • About Us
  • Genomic Testing
  • Resources
    • MedBen Rx Blog
    • Online Services, Forms & Formularies
  • Contact Us
  • MedBen Access
  • MedBen.com
Select Page

MedBen Rx Has Solutions for Rising Specialty Drug Costs

Dec 26, 2022 | MedBen Rx, Rx Costs, Rx prices, Rx Spending, Savings, Specialty Drugs

From earlier this year: “Health plans and pharmacy benefit managers (PBMs) that manage drug costs… say specialty drugs now account for 50% or greater of the total prescription spending they manage. In some cases, employer clients are seeing specialty costs account...

Many Drugs Seeing Price Increases in 2022

Jan 7, 2022 | Brand Name Drugs, Generic Drugs, MedBen Rx, Pharmacies, Prescription drugs, Rx Costs, Savings, Specialty Drugs

GoodRx is currently compiling a list of drugs that will cost consumers more in 2022. By January 17, 669 drugs will have experienced price increases, with an average increase of 5.0%. All but 11 on the list are brand-name medications. The list includes such well-known...

Save 10-40% on Rx Costs by Using the Most Effective Drugs

Nov 12, 2021 | Comparative Effectiveness, Evidence-based research, Generic Drugs, MedBen Rx, Prescription drugs, Rx Costs, Rx Spending, Savings, Specialty Drugs

MedBen Rx comparative effectiveness brings clinical research and employers together to find the most effective drugs at the best cost. You can save 10-40% on pharmacy costs by changing to drugs with better outcomes. The benefits of comparative effectiveness include:...

MedBen Rx Solutions Help Fight Drug Price Hikes

Jun 14, 2021 | Brand Name Drugs, Comparative Effectiveness, MedBen Rx, Prescription drugs, Rx Costs, Savings, Specialty Drugs

The prices of 260 popular brand-name prescription drugs rose 3% from 2019 to 2020 – twice as much as the 1.3% rate of inflation during the same period, according to a new AARP report. Their analysis also found that over the past 15 years, prices of 65 common brands...

January 2021 Drug Price Increases

Jan 10, 2021 | Brand Name Drugs, MedBen Rx, Rx Costs, Rx prices, Specialty Drugs

GoodRx has compiled a list of drugs that saw manufacturer price increases in January 2021. In total, 589 drugs – all but seven of them brand-name medications – increased in price, by an average of 4.2%. Among the better known brand-name drugs on the list are Humira...

Fraker, Fargus Featured Speakers at Healthcare Innovation Conference

Oct 20, 2020 | Brian Fargus, Caroline Fraker, MedBen employees, MedBen Rx, Pharmacogenomics, Specialty Drugs

MedBen Vice Presidents Caroline Fraker and Brian Fargus were among the featured speakers at the Sherrill-Morgan 7th Annual Healthcare Innovation Conference on Thursday, October 1. In her presentation, Senior Vice President Fraker discussed the potential problems of...
« Older Entries
Next Entries »

Categories

  • 340B
  • Access solution
  • Access solutions
  • Acquisition Cost Index (ACI)
  • Affordable Care Act
  • Anniversaries
  • Announcements
  • Appropriateness Solutions
  • Avande
  • Average Wholesale Price
  • Benefits Advisory Conference
  • Benefits preservation
  • Biologics
  • Biosimilar
  • Brand Name Drugs
  • Brian Fargus
  • Cancer
  • Caroline Fraker
  • Case Study
  • Cholesterol
  • Chronic conditions
  • Claims
  • Client Report
  • Clinical guidance
  • Comparative Effectiveness
  • Compliance
  • Consolidated Appropriations Act of 2021 (CAA)
  • Cost Plus
  • Cost Plus Pricing
  • Cost projections
  • Cost Savings
  • Diabetes
  • Discounts
  • Doug Freeman
  • Drug costs
  • Drug makers
  • Drug marketing
  • Drug reimportation
  • Evidence-based research
  • Federal Trade Commission (FTC)
  • Food and Drug Administration (FDA)
  • Formularies
  • Fraud
  • Gene therapy
  • Generic Drugs
  • Genetic testing
  • Genomics
  • GLP-1s
  • Government
  • Guarantees
  • Health and Human Services
  • Health systems
  • Heart medications
  • High-value formulary
  • History
  • Humalog
  • Humira
  • Idacio
  • Inflation
  • Kurt Harden
  • Lawsuits
  • Legislation
  • Lifestyle
  • Limited Use HRA
  • Lobbying
  • Luke Burchard
  • MDMA (ecstasy)
  • MedBen
  • MedBen Access
  • MedBen Basics
  • MedBen Board of Directors\
  • MedBen employees
  • MedBen Rx
  • MedBen Rx Advocate
  • MedBen Rx Alliance
  • MedBen Rx News
  • MedBen University
  • Medicaid
  • Medicare
  • Mental health
  • Mobile app
  • Mounjaro
  • News
  • Nutrigenomics
  • Obesity
  • Online Services
  • Opinions
  • Outcomes
  • Overprescribing
  • Own Use
  • Ozempic
  • Patient advocacy program
  • Patient assistance program
  • Perigon Pharmacy 360
  • Pharmacies
  • Pharmacogenomics
  • Pharmacy Benefits Manager (PBM)
  • Pharmacy Services Administrator (PSA)
  • Precision medicine
  • Prescription drugs
  • Prescription Portal
  • Pricing solutions
  • Psychedelic drugs
  • Rebates
  • Regulatory
  • Reporting
  • Research
  • Rx Advertising
  • Rx Costs
  • Rx Facts
  • Rx prices
  • Rx Spending
  • RxDC report
  • Savings
  • Specialty Drugs
  • Spread Pricing
  • State legislation
  • Statins
  • Stelara
  • Study
  • Surveys
  • Transparency
  • Trend
  • TruDataRx
  • Trulicity
  • Value
  • Ventegra
  • Wegovy
  • Weight loss
  • Weight loss drugs
  • Weight management
  • Wellness
  • White paper
  • Zepbound
  • About Us
  • Contact Us
  • Blog
  • Online Services
  • MedBen Access
  • Sitemap
  • Privacy
  • MedBen.com

Sign Up for our Newsletter

  • This field is for validation purposes and should be left unchanged.
© 2026 MedBen Rx. All rights reserved.